Scarica l'app Stockscreener
1.98
2.46%
-0.05
Celularity Inc Borsa (CELU) Ultime notizie
Two Sigma Investments LP Invests $93,000 in Celularity Inc. (NASDAQ:CELU) - Defense World
Celularity (NASDAQ:CELU) Shares Down 10.4% – Here’s Why - Defense World
# Celularity terminates CFO, appoints interim replacement By Investing.com - Investing.com South Africa
Celularity stock falls after CFO David Beers terminated By Investing.com - Investing.com Nigeria
Celularity stock falls after CFO David Beers terminated - Investing.com Australia
# Celularity terminates CFO, appoints interim replacement - Investing.com Australia
Celularity (CELU) Appoints Interim CFO After Terminating Current CFO | CELU Stock News - GuruFocus
Celularity Names Joseph DosSantos Interim CFO - MarketScreener
Celularity Announces Chief Financial Officer Transition - marketscreener.com
Celularity terminates CFO David Beers - TipRanks
Celularity Announces Sudden CFO Departure, Taps Internal Talent and External Advisory Firm - Stock Titan
Celularity announces publication on advancing ocular surface reconstruction - TipRanks
Celularity Announces Publication Advancing Ocular Surface Reconstruction with Tri-Layer Amniotic Membrane Technology - marketscreener.com
Celularity (CELU) Advances Stem Cell Research with Innovative Bi - GuruFocus
Revolutionary Stem Cell Breakthrough: New Technology Could Transform Eye Disease Treatment - Stock Titan
Celularity Receives Nasdaq Notice Regarding Form 10-Q - The Manila Times
Celularity Inc. Notified by Nasdaq of Non-Compliance with Quarterly Filing Requirements - Nasdaq
Celularity Gets 60 Days to Fix Nasdaq Compliance After Missing Q1 Filing Deadline - Stock Titan
Reklaim Ltd. Reports Record 73% Revenue Growth in Q1 2025 and Launches Subscription Privacy Service - The Globe and Mail
Celularity (NASDAQ:CELU) Trading 7.4% Higher – Here’s Why - Defense World
Celularity extends debt maturity, issues stock to YA II PN By Investing.com - Investing.com India
Celularity extends debt maturity, issues stock to YA II PN - Investing.com Australia
Celularity Extends Note Maturity with YA II PN - TipRanks
Celularity Inc. Advances Placental-Derived Therapies - TipRanks
Celularity (CELU) Reports Significant Revenue Growth in FY24 | C - GuruFocus
Celularity Announces Full Year 2024 Operating and Financial Results - The Manila Times
Celularity Inc. Reports Strong Financial Growth and Increased Revenue for Year Ended December 31, 2024 - Nasdaq
Celularity Inc SEC 10-K Report - TradingView
Nvidia (NVDA) Targets Trillion Dollar Opportunity as Trump Ponders Lifting AI Chip Curbs - The Globe and Mail
Should You Buy PayPal Stock on the Dip in May 2025? - The Globe and Mail
The end of La Niña: Lessons about Plains wheat drought & why spring weather is bearish for most grain markets - The Globe and Mail
Earnings To Watch: Caesars Entertainment (CZR) Reports Q1 Results Tomorrow - The Globe and Mail
Celularity (CELU) Resolves Nasdaq Fee Issue to Avoid Delisting | - GuruFocus
Celularity (NASDAQ:CELU) Stock Price Down 4.7% – Time to Sell? - Defense World
Celularity pays $70,000 fee to Nasdaq following receipt of notice - MSN
Celularity Receives Nasdaq Notice Regarding Non-Payment of Nasdaq Fees - The Manila Times
Celularity Inc. Faces Potential Delisting from Nasdaq Due to Fee and Filing Delinquencies - Nasdaq
Celularity Given Until May 1 to Address Dual Nasdaq Compliance Issues or Face Delisting - Stock Titan
Celularity faces Nasdaq delisting over late filing By Investing.com - Investing.com India
Celularity faces Nasdaq delisting over late filing - Investing.com
Looking for Exposure to Nvidia Stock? Try These Two ETFs - The Globe and Mail
Markel Group to give a presentation at the beginning of its annual Omaha Brunch - The Globe and Mail
Celularity Welcomes CMS Action on Medicare Local Coverage Determination for Skin Substitutes Products - The Manila Times
CMS Extends Medicare Coverage for Wound Care Products: Major Win for Skin Substitute Market - Stock Titan
Revolutionary NK Cell Therapy Shows Promise in Cancer Treatment: New Research Reveals - Stock Titan
0.68%
0.50%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):